Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 443

1.

Functional parameters derived from magnetic resonance imaging reflect vascular morphology in preclinical tumors and in human liver metastases.

Kannan P, Kretzschmar WW, Winter H, Warren DR, Bates R, Allen PD, Syed N, Irving B, Papie┼╝ BW, Kaeppler J, Markelc B, Kinchesh P, Gilchrist S, Smart SC, Schnabel JA, Maughan TS, Harris AL, Muschel RJ, Partridge M, Sharma RA, Kersemans V.

Clin Cancer Res. 2018 Jun 29. pii: clincanres.0033.2018. doi: 10.1158/1078-0432.CCR-18-0033. [Epub ahead of print]

PMID:
29959141
2.

Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study.

Sivapalasingam S, Kamal M, Slim R, Hosain R, Shao W, Stoltz R, Yen J, Pologe LG, Cao Y, Partridge M, Sumner G, Lipsich L.

Lancet Infect Dis. 2018 Jun 18. pii: S1473-3099(18)30397-9. doi: 10.1016/S1473-3099(18)30397-9. [Epub ahead of print]

PMID:
29929783
3.

Resource utilization and outcome among patients with selective versus nonselective troponin testing.

Campbell AR, Rodriguez AJ, Larson DM, Strauss CE, Garberich RF, Partridge MF, Henry TD, Sharkey SW.

Am Heart J. 2018 May;199:68-74. doi: 10.1016/j.ahj.2018.01.010. Epub 2018 Jan 31.

PMID:
29754668
4.

Reflections on integrated care from those working in and leading integrated respiratory teams.

Roberts NJ, Ward M, Patel I, Yorke J, Partridge MR.

London J Prim Care (Abingdon). 2018 Jan 1;10(2):24-30. doi: 10.1080/17571472.2017.1421020. eCollection 2018 Mar.

5.

Stomach Dose-Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer.

Holyoake DLP, Warren DR, Hurt C, Aznar M, Partridge M, Mukherjee S, Hawkins MA.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):418-426. doi: 10.1016/j.clon.2018.02.067. Epub 2018 Mar 28.

PMID:
29602584
6.

The Use of Social Media to Combat Research-Isolation.

Reeve MA, Partridge M.

Ann Entomol Soc Am. 2017 Sep;110(5):449-456. doi: 10.1093/aesa/sax051. Epub 2017 Sep 6.

7.

Green respiratory health care: Time for us all to act.

Hui CK, Xu B, Chung KF, Partridge MR.

Respirology. 2018 May;23(5):452-454. doi: 10.1111/resp.13281. Epub 2018 Mar 6. No abstract available.

8.

Ten simple rules for drawing scientific comics.

McDermott JE, Partridge M, Bromberg Y.

PLoS Comput Biol. 2018 Jan 4;14(1):e1005845. doi: 10.1371/journal.pcbi.1005845. eCollection 2018 Jan. No abstract available.

9.

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.

Warren S, Hurt CN, Crosby T, Partridge M, Hawkins MA.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):729-737. doi: 10.1016/j.ijrobp.2017.07.025. Epub 2017 Jul 29.

10.

2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).

Gupta S, Richards S, Amaravadi L, Piccoli S, Desilva B, Pillutla R, Stevenson L, Mehta D, Carrasco-Triguero M, Neely R, Partridge M, Staack RF, Zhao X, Gorovits B, Kolaitis G, Sumner G, Stubenrauch KG, Zou L, Amur S, Beaver C, Berger I, Berisha F, Birnboeck H, Bower J, Cho SJ, Cludts I, Cocea L, Donato LD, Fischer S, Fraser S, Garofolo F, Haidar S, Haulenbeek J, Hottenstein C, Hu J, Ishii-Watabe A, Islam R, Jani D, Kadavil J, Kamerud J, Kramer D, Kurki P, MacMannis S, McNally J, Mullan A, Papadimitriou A, Pedras-Vasconcelos J, Ray S, Safavi A, Saito Y, Savoie N, Fjording MS, Scheibner K, Smeraglia J, Song A, Stouffer B, Tampal N, der Strate BV, Verch T, Welink J, Xu Y, Yang TY, Yengi L, Zeng J, Zhang Y, Zhang Y, Zoog S.

Bioanalysis. 2017 Dec;9(24):1967-1996. doi: 10.4155/bio-2017-4974. Epub 2017 Dec 5.

11.

A pictorial Sleepiness and Sleep Apnoea Scale to recognize individuals with high risk for obstructive sleep apnea syndrome.

Edelmann C, Ghiassi R, Vogt DR, Partridge MR, Khatami R, Leuppi JD, Miedinger D.

Nat Sci Sleep. 2017 Oct 25;9:253-265. doi: 10.2147/NSS.S139936. eCollection 2017.

12.

[18F]Fluoromisonidazole PET in rectal cancer.

Puri T, Greenhalgh TA, Wilson JM, Franklin J, Wang LM, Strauss V, Cunningham C, Partridge M, Maughan T.

EJNMMI Res. 2017 Sep 20;7(1):78. doi: 10.1186/s13550-017-0324-x.

13.

Sensitivity Enhancement in Low Cutoff Wavelength Long-Period Fiber Gratings by Cladding Diameter Reduction.

Del Villar I, Partridge M, Rodriguez WE, Fuentes O, Socorro AB, Diaz S, Corres JM, James SW, Tatam RP.

Sensors (Basel). 2017 Sep 13;17(9). pii: E2094. doi: 10.3390/s17092094.

14.

An approximate analytical solution of the Bethe equation for charged particles in the radiotherapeutic energy range.

Grimes DR, Warren DR, Partridge M.

Sci Rep. 2017 Aug 29;7(1):9781. doi: 10.1038/s41598-017-10554-0.

15.

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data.

Holyoake DLP, Aznar M, Mukherjee S, Partridge M, Hawkins MA.

Radiother Oncol. 2017 Jun;123(3):431-437. doi: 10.1016/j.radonc.2017.04.024. Epub 2017 Jun 6.

16.

Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc-Fc interactions.

Partridge MA, Vijayam U, Karayusuf EK, Shum E, Sirimanne T, Garlits J, Chen J, Torri A, Sumner G.

Bioanalysis. 2017 May;9(9):707-717. doi: 10.4155/bio-2017-0011. Epub 2017 May 10.

PMID:
28488898
17.

Volatile Organic Compounds Sensing Using Optical Fibre Long Period Grating with Mesoporous Nano-Scale Coating.

Hromadka J, Korposh S, Partridge M, James SW, Davis F, Crump D, Tatam RP.

Sensors (Basel). 2017 Feb 8;17(2). pii: E205. doi: 10.3390/s17020205.

18.

Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy.

Wilson JM, Mukherjee S, Brunner TB, Partridge M, Hawkins MA.

Clin Oncol (R Coll Radiol). 2017 Jun;29(6):370-377. doi: 10.1016/j.clon.2017.01.038. Epub 2017 Feb 9.

19.
20.

Overwrite fabrication and tuning of long period gratings.

Partridge M, James SW, Barrington J, Tatam RP.

Opt Express. 2016 Oct 3;24(20):22345-22356. doi: 10.1364/OE.24.022345.

PMID:
27828306
21.

Unwrapping 3D complex hollow organs for spatial dose surface analysis.

Witztum A, George B, Warren S, Partridge M, Hawkins MA.

Med Phys. 2016 Nov;43(11):6009.

PMID:
27806596
22.

Imaging biomarker roadmap for cancer studies.

O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC.

Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. doi: 10.1038/nrclinonc.2016.162. Epub 2016 Oct 11. Review.

23.

Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

Ramroth J, Cutter DJ, Darby SC, Higgins GS, McGale P, Partridge M, Taylor CW.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):736-747. doi: 10.1016/j.ijrobp.2016.07.022. Epub 2016 Jul 25.

24.

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.

Holyoake DL, Robinson M, Grose D, McIntosh D, Sebag-Montefiore D, Radhakrishna G, Patel N, Partridge M, Mukherjee S, Hawkins MA.

Radiother Oncol. 2016 Oct;121(1):86-91. doi: 10.1016/j.radonc.2016.08.001. Epub 2016 Aug 9.

25.

Recent Advances in Assessing Immunogenicity of Therapeutic Proteins: Impact on Biotherapeutic Development.

Lu Y, Khawli LA, Purushothama S, Theil FP, Partridge MA.

J Immunol Res. 2016;2016:8141269. doi: 10.1155/2016/8141269. Epub 2016 Aug 23. No abstract available.

26.

Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.

Partridge MA, Purushothama S, Elango C, Lu Y.

J Immunol Res. 2016;2016:6262383. doi: 10.1155/2016/6262383. Epub 2016 Jul 31. Review.

27.

The impact of personalisation on people from Chinese backgrounds: qualitative accounts of social care experience.

Irvine F, Wah Yeung EY, Partridge M, Simcock P.

Health Soc Care Community. 2017 May;25(3):878-887. doi: 10.1111/hsc.12374. Epub 2016 Aug 8.

PMID:
27501480
28.

Correction to 'Estimating oxygen distribution from vasculature in three-dimensional tumour tissue'.

Grimes DR, Kannan P, Warren DR, Markelc B, Bates R, Muschel R, Partridge M.

J R Soc Interface. 2016 Jun;13(119). pii: 20160362. doi: 10.1098/rsif.2016.0362. No abstract available.

29.

Fine Motor Differences and Prenatal Serotonin Reuptake Inhibitors Exposure.

Partridge MC, Salisbury AL, LaGasse LL.

J Pediatr. 2016 Aug;175:144-149.e1. doi: 10.1016/j.jpeds.2016.04.065. Epub 2016 May 20.

30.

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Wilson JM, Fokas E, Dutton SJ, Patel N, Hawkins MA, Eccles C, Chu KY, Durrant L, Abraham AG, Partridge M, Woodward M, O'Neill E, Maughan T, McKenna WG, Mukherjee S, Brunner TB.

Radiother Oncol. 2016 May;119(2):306-11. doi: 10.1016/j.radonc.2016.03.021. Epub 2016 Apr 23.

31.

The Role of Oxygen in Avascular Tumor Growth.

Grimes DR, Kannan P, McIntyre A, Kavanagh A, Siddiky A, Wigfield S, Harris A, Partridge M.

PLoS One. 2016 Apr 18;11(4):e0153692. doi: 10.1371/journal.pone.0153692. eCollection 2016.

32.

An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.

Warren S, Partridge M, Bolsi A, Lomax AJ, Hurt C, Crosby T, Hawkins MA.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):199-207. doi: 10.1016/j.ijrobp.2016.01.044. Epub 2016 Jan 30.

33.

Definition of a COPD self-management intervention: International Expert Group consensus.

Effing TW, Vercoulen JH, Bourbeau J, Trappenburg J, Lenferink A, Cafarella P, Coultas D, Meek P, van der Valk P, Bischoff EW, Bucknall C, Dewan NA, Early F, Fan V, Frith P, Janssen DJ, Mitchell K, Morgan M, Nici L, Patel I, Walters H, Rice KL, Singh S, Zuwallack R, Benzo R, Goldstein R, Partridge MR, van der Palen J.

Eur Respir J. 2016 Jul;48(1):46-54. doi: 10.1183/13993003.00025-2016. Epub 2016 Apr 13.

34.

Estimating oxygen distribution from vasculature in three-dimensional tumour tissue.

Grimes DR, Kannan P, Warren DR, Markelc B, Bates R, Muschel R, Partridge M.

J R Soc Interface. 2016 Mar;13(116). pii: 20160070. doi: 10.1098/rsif.2016.0070. Erratum in: J R Soc Interface. 2016 Jun;13(119). pii: 20160362. doi: 10.1098/rsif.2016.0362.

35.

A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio.

Grimes DR, Partridge M.

Biomed Phys Eng Express. 2015 Dec 4;1(4):045209.

36.

Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.

Hill EJ, Roberts C, Franklin JM, Enescu M, West N, MacGregor TP, Chu KY, Boyle L, Blesing C, Wang LM, Mukherjee S, Anderson EM, Brown G, Dutton S, Love SB, Schnabel JA, Quirke P, Muschel R, McKenna WG, Partridge M, Sharma RA.

Clin Cancer Res. 2016 Apr 15;22(8):1922-31. doi: 10.1158/1078-0432.CCR-15-1489. Epub 2016 Feb 9.

37.

An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.

Partridge MA, Gopinath S, Myers SJ, Coorssen JR.

J Chem Biol. 2015 Jun 12;9(1):9-18. doi: 10.1007/s12154-015-0138-0. eCollection 2016 Jan.

38.

The diagnosis of COPD in primary care; gender differences and the role of spirometry.

Roberts NJ, Patel IS, Partridge MR.

Respir Med. 2016 Feb;111:60-3. doi: 10.1016/j.rmed.2015.12.008. Epub 2015 Dec 19.

39.

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation.

Carrington R, Staffurth J, Warren S, Partridge M, Hurt C, Spezi E, Gwynne S, Hawkins MA, Crosby T.

Radiat Oncol. 2015 Nov 19;10:236. doi: 10.1186/s13014-015-0537-y.

40.

Matrix interference from Fc-Fc interactions in immunoassays for detecting human IgG4 therapeutics.

Partridge MA, Karayusuf EK, Dhulipala G, Dreyer R, Daly T, Sumner G, Pyles E, Torri A.

Bioanalysis. 2015;7(20):2701-12. doi: 10.4155/bio.15.152. Epub 2015 Oct 27.

PMID:
26505555
41.

Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data.

Borri M, Schmidt MA, Powell C, Koh DM, Riddell AM, Partridge M, Bhide SA, Nutting CM, Harrington KJ, Newbold KL, Leach MO.

PLoS One. 2015 Sep 23;10(9):e0138545. doi: 10.1371/journal.pone.0138545. eCollection 2015.

42.

A tumor control probability model for anal squamous cell carcinoma.

Muirhead R, Partridge M, Hawkins MA.

Radiother Oncol. 2015 Aug;116(2):192-6. doi: 10.1016/j.radonc.2015.07.014. Epub 2015 Aug 1. Review.

PMID:
26243680
43.

Television Advertising of Medicines. Unexpected Consequences?

Partridge MR.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):2-3. doi: 10.1164/rccm.201505-0869ED. No abstract available.

PMID:
26131985
44.

The use of an online pictorial Epworth Sleepiness Scale in the assessment of age and gender specific differences in excessive daytime sleepiness.

Drakatos P, Ghiassi R, Jarrold I, Harris J, Abidi A, Douiri A, Hart N, Kosky C, Williams AJ, Partridge MR, Steier J.

J Thorac Dis. 2015 May;7(5):897-902. doi: 10.3978/j.issn.2072-1439.2014.06.11.

45.

Satisfaction with social care: the experiences of people from Chinese backgrounds with physical disabilities.

Yeung EY, Partridge M, Irvine F.

Health Soc Care Community. 2016 Nov;24(6):e144-e154. doi: 10.1111/hsc.12264. Epub 2015 Jun 21.

PMID:
26094871
46.

Oxygen consumption dynamics in steady-state tumour models.

Grimes DR, Fletcher AG, Partridge M.

R Soc Open Sci. 2014 Sep 24;1(1):140080. doi: 10.1098/rsos.140080. eCollection 2014 Sep.

47.

Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts.

Kersemans V, Kannan P, Beech JS, Bates R, Irving B, Gilchrist S, Allen PD, Thompson J, Kinchesh P, Casteleyn C, Schnabel J, Partridge M, Muschel RJ, Smart SC.

PLoS One. 2015 Jun 5;10(6):e0128537. doi: 10.1371/journal.pone.0128537. eCollection 2015.

48.

Improved calibration of mass stopping power in low density tissue for a proton pencil beam algorithm.

Warren DR, Partridge M, Hill MA, Peach K.

Phys Med Biol. 2015 Jun 7;60(11):4243-61. doi: 10.1088/0031-9155/60/11/4243. Epub 2015 May 14.

PMID:
25973866
49.

Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.

Riches SF, Payne GS, Morgan VA, Dearnaley D, Morgan S, Partridge M, Livni N, Ogden C, deSouza NM.

Eur Radiol. 2015 May;25(5):1247-56. doi: 10.1007/s00330-014-3479-0. Epub 2015 Mar 7.

PMID:
25749786
50.

3D calculation of radiation-induced second cancer risk including dose and tissue response heterogeneities.

Timlin C, Warren DR, Rowland B, Madkhali A, Loken J, Partridge M, Jones B, Kruse J, Miller R.

Med Phys. 2015 Feb;42(2):866-76. doi: 10.1118/1.4905158.

PMID:
25652499

Supplemental Content

Loading ...
Support Center